Brief: Shield Therapeutics Says H1 Revenue $4.3 Mln Vs $2.6 Mln Year Ago

Shield Therapeutics

28/09/2023 08:01

Sept 28 (Reuters) - Shield Therapeutics PLC  STXS.L :
    * INTERIM RESULTS UPDATE AND BUSINESS UPDATE
    * H1 REVENUE 4.3 MILLION USD VERSUS 2.6 MILLION USD YEAR AGO
    * ACCELERATING PRESCRIPTION GROWTH, WITH EXPECTATIONS FOR
80%
INCREASE IN Q3 2023
    * NEW $20 MILLION TERM LOAN & EQUITY FINANCING TO EXPAND
WORKING
CAPITAL, FORTIFYING PLANS TO REACH CASH FLOW BREAK-EVEN BY END
OF 2024

Source text for Eikon:  ID:nRSb9177Na 
Further company coverage:  STXS.L 

 (Reuters.Briefs@thomsonreuters.com)